Alzheimer's Disease: Genetics

Alzheimer's disease is a neurodegenerative disease. Discover genetic and epigenetic aspects of Alzheimer’s disease, including genetic markers and genomic structural variations with this feed.

January 15, 2021

Multiclass classification of patients during different stages of Alzheimer's disease using fMRI time-series

Biomedical Physics & Engineering Express
Hessam AhmadiAli Motie-Nasrabadi
January 19, 2021
Preprint
Open Access

Identifying neuron subtype-specific metabolic network changes in single cell transcriptomics of Alzheimer's Disease using perturb-Met

BioRxiv : the Preprint Server for Biology
Yuliang Wang
January 16, 2021
Preprint
Open Access

Development of Novel Measures for Alzheimer's Disease Prevention Trials (NoMAD)

MedRxiv : the Preprint Server for Health Sciences
S. A. BellTerry E. Goldberg
January 22, 2021

The complexity of Alzheimer's disease: an evolving puzzle.

Physiological Reviews
Sandro Sorbi, Camilla Ferrari
January 20, 2021
Open Access

Prime Editing Guide RNA Design Automation Using PINE-CONE

ACS Synthetic Biology
Kylie Standage-BeierXiao Wang
January 21, 2021

Global and Regional Changes in Perivascular Space in Idiopathic and Familial Parkinson's Disease.

Movement Disorders : Official Journal of the Movement Disorder Society
Erin K DonahueFarshid Sepehrband
January 19, 2021
Review
Open Access

Plasma Lipids as Biomarkers for Alzheimer's Disease: A Systematic Review

Curēus
Mehak Agarwal, Safeera Khan
January 18, 2021

Applying available knowledge and resources to alleviate familial and sporadic neurodegenerative disorders

Progress in Molecular Biology and Translational Science
Mark P Mattson
January 18, 2021

Inflammation and Parkinson's disease pathogenesis: Mechanisms and therapeutic insight

Progress in Molecular Biology and Translational Science
Gianluigi ForloniClaudia Balducci
January 15, 2021

A phosphorylation-dependent switch in the disordered p53 transactivation domain regulates DNA binding

Proceedings of the National Academy of Sciences of the United States of America
Xun SunPeter E Wright
January 20, 2021
Review
Open Access

Early-Onset Alzheimer's Disease: What Is Missing in Research?

Current Neurology and Neuroscience Reports
Temitope AyodeleChristiane Reitz
January 14, 2021
Preprint
Open Access

ApoE4 attenuates cortical neuronal activity and impairs memory in young apoE4 rats

BioRxiv : the Preprint Server for Biology
I. Har-PazAnan Moran
January 18, 2021

The cellular machinery of post-endocytic APP trafficking in Alzheimer's disease: A future target for therapeutic intervention?

Progress in Molecular Biology and Translational Science
Lawrence S B Goldstein, Utpal Das
January 18, 2021
Preprint
Open Access

Gene Expression Profiles Underlying Aggressive Behavior in the Prefrontal Cortex of Cattle

ResearchSquare
Paulina G. EusebiSusana Dunner
January 19, 2021
Open Access

Modifiable, Non-Modifiable, and Clinical Factors Associated with Progression of Alzheimer's Disease

Journal of Alzheimer's Disease : JAD
David A Loeffler

Sign up to follow this feed and discover related papers.

Related Feeds

3D Cellular Models of Brain and Neurodegeneration

Brain organoids are three-dimensional in vitro cellular models of the brain that can recapitulate many processes such as the neurodevelopment. In addition, these organoids can be combined with other cell types, such as neurons and astrocytes to study their interactions in assembloids. Disease processes can also be modeled by induced pluripotent stem cell-derived organoids and assembloids from patients with neurodegenerative disorders. Discover the latest research on the models here.

AAV-based Gene Therapy

Adeno-associated virus (AAV)-based gene therapy is a biological vector that is being researched to be used as a potential therapeutic option. This gene therapy is designed to insert fragments of DNA into targeted cells to help treat diseases, such as hemophilia a. Discover the latest research on AAV-based gene therapy here.

ALS & FTD: TDP-43

TAR DNA-binding protein 43 (TDP-43) is a pathological protein identified in sporadic Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). Here are the latest discoveries pertaining to TDP-43 and these diseases.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Pathogenic Mechanisms

Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS: Phenotypes

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disorder characterized phenotypically by progressive muscle weakness. Clinical phenotypes of ALS can be classified based on the pattern, level, and area of onset (e.g. bulbar, cervical, lumbar). Here is the latest research investigating phenotypes of ALS.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here is the latest research on ALS and prions.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research in this field.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS) is associated with the death of neurons that control voluntary muscles. This feed followes the latest research into therapies for this progressive neurodegenerative disease.

Acute Myeloid Leukaemia & RNA

Acute myeloid leukaemia (AML) is a common hematological type of cancer. As the population ages, there has been a rise in the frequency of AML. RNA expression has been used to see if there are different genetic profiles that exist within AML and whether these may underpin the variations in survival rates. Here is the latest research on AML and RNA.

© 2021 Meta ULC. All rights reserved
/feed-previews/alzheimers-disease-genetics/8db592be-740e-4d70-9f24-28ffc33168b7